VENKEYS
Venky's (India) Limited
Poultry and allied agribusiness company with oilseed and animal health products division
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Food Products›Meat Products including Poultry
venkys.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Venky's (India) is a poultry and agribusiness company that sells day-old chicks and broiler birds, makes animal health products and processes oilseeds.
Company snapshot
1stBy market cap
Ranked among 3 companies in Meat Products including Poultry.
Segment mix
Reportable segments as of 2024-12-31 (Standalone). Revenue share = segment revenue ÷ total revenue.
Largest segment: 55.7% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Animal Health Products | 10.0% | 88 Cr | 18 Cr | 243 Cr |
| Oilseed | 37.0% | 326 Cr | 8 Cr | 684 Cr |
| Poultry and poultry products | 55.7% | 491 Cr | 15 Cr | 842 Cr |
Shares add up to 103% because segment revenues are before inter-segment eliminations.
What we see
- ✓Debt-to-equity of 0.10x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 913 Cr | 953 Cr | 896 Cr | 808 Cr | 774 Cr | 882 Cr | 843 Cr | 866 Cr | 801 Cr | 960 Cr | 1,100 Cr | 1,118 Cr |
| Operating expenses (approx.) | 863 Cr | 960 Cr | 846 Cr | 705 Cr | 760 Cr | 853 Cr | 818 Cr | 842 Cr | 832 Cr | 890 Cr | 971 Cr | 1,049 Cr |
| EBITDA | 50 Cr | -7 Cr | 50 Cr | 103 Cr | 14 Cr | 29 Cr | 25 Cr | 24 Cr | -31 Cr | 70 Cr | 130 Cr | 69 Cr |
| OPM % | 5.4% | -0.8% | 5.6% | 12.8% | 1.8% | 3.3% | 3.0% | 2.7% | -3.9% | 7.3% | 11.8% | 6.2% |
| Other income | 9 Cr | 10 Cr | 11 Cr | 10 Cr | 10 Cr | 12 Cr | 12 Cr | 12 Cr | 10 Cr | 10 Cr | 16 Cr | 13 Cr |
| Interest | 5 Cr | 5 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 5 Cr | 4 Cr | 3 Cr | 4 Cr |
| Depreciation | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 10 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr |
| Profit before tax | 46 Cr | -10 Cr | 47 Cr | 101 Cr | 11 Cr | 28 Cr | 21 Cr | 22 Cr | -35 Cr | 66 Cr | 127 Cr | 69 Cr |
| Tax % | 25.6% | 24.2% | 29.4% | 25.5% | 29.5% | 26.8% | 43.7% | 27.3% | 24.4% | 26.5% | 23.5% | 27.8% |
| Net profit | 34 Cr | -8 Cr | 34 Cr | 75 Cr | 8 Cr | 20 Cr | 12 Cr | 16 Cr | -27 Cr | 49 Cr | 97 Cr | 50 Cr |
| EPS (₹) | ₹24.20 | ₹-5.63 | ₹23.78 | ₹53.36 | ₹5.51 | ₹14.47 | ₹9.44 | ₹11.24 | ₹-18.83 | ₹34.48 | ₹71.96 | ₹35.49 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,476 Cr | 2,689 Cr | 3,043 Cr | 3,261 Cr | 3,117 Cr | 4,400 Cr | 4,234 Cr | 3,738 Cr | 3,307 Cr | 3,727 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 2,198 Cr | 2,300 Cr | 2,735 Cr | 3,282 Cr | 2,728 Cr | 4,156 Cr | 4,122 Cr | 3,615 Cr | 3,135 Cr | 3,535 Cr | Sign in free for the trailing twelve months |
| EBITDA | 277 Cr | 389 Cr | 308 Cr | -21 Cr | 389 Cr | 244 Cr | 112 Cr | 123 Cr | 172 Cr | 192 Cr | Sign in free for the trailing twelve months |
| OPM % | 11.2% | 14.5% | 10.1% | -0.7% | 12.5% | 5.6% | 2.6% | 3.3% | 5.2% | 5.2% | Sign in free for the trailing twelve months |
| Other income | 34 Cr | 26 Cr | 29 Cr | 35 Cr | 36 Cr | 36 Cr | 38 Cr | 39 Cr | 44 Cr | 48 Cr | Sign in free for the trailing twelve months |
| Interest | 77 Cr | 50 Cr | 32 Cr | 30 Cr | 28 Cr | 18 Cr | 18 Cr | 18 Cr | 16 Cr | 17 Cr | Sign in free for the trailing twelve months |
| Depreciation | 28 Cr | 28 Cr | 29 Cr | 34 Cr | 35 Cr | 37 Cr | 35 Cr | 35 Cr | 37 Cr | 37 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 206 Cr | 337 Cr | 277 Cr | -50 Cr | 361 Cr | 227 Cr | 95 Cr | 109 Cr | 161 Cr | 179 Cr | Sign in free for the trailing twelve months |
| Tax % | 39.4% | 40.7% | 37.0% | 45.4% | 25.8% | 27.2% | 26.0% | 27.7% | 28.4% | 24.9% | Sign in free for the trailing twelve months |
| Net profit | 125 Cr | 200 Cr | 174 Cr | -27 Cr | 268 Cr | 165 Cr | 70 Cr | 79 Cr | 115 Cr | 135 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹88.55 | ₹141.76 | ₹123.62 | ₹-19.28 | ₹190.06 | ₹116.97 | ₹50.03 | ₹56.13 | ₹82.78 | ₹98.85 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 0.1% | 14.4% | 25.8% | 10.8% | 8.4% | 10.6% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr | 14 Cr |
| Reserves | 517 Cr | 707 Cr | 867 Cr | 822 Cr | 1,090 Cr | 1,235 Cr | 1,285 Cr | 1,356 Cr | 1,461 Cr | 1,582 Cr |
| Borrowings | 470 Cr | 247 Cr | 229 Cr | 275 Cr | 174 Cr | 192 Cr | 185 Cr | 168 Cr | 165 Cr | 163 Cr |
| Other liabilities | 359 Cr | 463 Cr | 447 Cr | 486 Cr | 512 Cr | 506 Cr | 531 Cr | 556 Cr | 430 Cr | 550 Cr |
| Total liabilities | 1,360 Cr | 1,431 Cr | 1,557 Cr | 1,597 Cr | 1,790 Cr | 1,947 Cr | 2,015 Cr | 2,094 Cr | 2,070 Cr | 2,309 Cr |
| Fixed assets (net) | 455 Cr | 459 Cr | 491 Cr | 554 Cr | 604 Cr | 586 Cr | 578 Cr | 603 Cr | 631 Cr | 633 Cr |
| CWIP | 8 Cr | 17 Cr | 66 Cr | 53 Cr | 10 Cr | 14 Cr | 34 Cr | 28 Cr | 8 Cr | 9 Cr |
| Investments | 2 Cr | — | 6 Cr | 7 Cr | 45 Cr | 76 Cr | 90 Cr | 105 Cr | 122 Cr | 216 Cr |
| Loans & advances | — | — | 1 Cr | 1 Cr | 1 Cr | 2 Cr | 0 Cr | 0 Cr | 9 Cr | 0 Cr |
| Inventories | 115 Cr | 162 Cr | 209 Cr | 111 Cr | 218 Cr | 185 Cr | 196 Cr | 172 Cr | 248 Cr | 329 Cr |
| Trade receivables | 264 Cr | 295 Cr | 306 Cr | 448 Cr | 390 Cr | 638 Cr | 656 Cr | 715 Cr | 554 Cr | 544 Cr |
| Cash & bank | 27 Cr | 9 Cr | 9 Cr | 5 Cr | 53 Cr | 6 Cr | 20 Cr | 19 Cr | 17 Cr | 62 Cr |
| Other assets | 489 Cr | 488 Cr | 469 Cr | 417 Cr | 467 Cr | 439 Cr | 440 Cr | 452 Cr | 482 Cr | 516 Cr |
| Total assets | 1,360 Cr | 1,431 Cr | 1,557 Cr | 1,597 Cr | 1,790 Cr | 1,947 Cr | 2,015 Cr | 2,094 Cr | 2,070 Cr | 2,309 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 211 Cr | 256 Cr | 159 Cr | 58 Cr | 242 Cr | 5 Cr | 86 Cr | 82 Cr | 66 Cr | 191 Cr |
| Cash from investing | 57 Cr | -29 Cr | -38 Cr | -53 Cr | -46 Cr | -18 Cr | -27 Cr | -37 Cr | -38 Cr | -108 Cr |
| Cash from financing | -280 Cr | -245 Cr | -120 Cr | -9 Cr | -148 Cr | -34 Cr | -45 Cr | -47 Cr | -30 Cr | -36 Cr |
| Net cash flow | -12 Cr | -18 Cr | 0.22 Cr | -4 Cr | 48 Cr | -47 Cr | 15 Cr | -2 Cr | -2 Cr | 47 Cr |
| Free cash flow (OCF − Capex) | 186 Cr | 209 Cr | 57 Cr | -26 Cr | 206 Cr | -25 Cr | 44 Cr | 32 Cr | 20 Cr | 150 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 28.3% | 40.0% | 27.7% | -1.8% | 30.4% | 16.9% | 7.7% | 8.3% | 10.8% | 11.2% |
| ROE % | 23.5% | 27.7% | 19.8% | -3.2% | 24.2% | 13.2% | 5.4% | 5.8% | 7.8% | 8.4% |
| Debtor days | 39 | 40 | 37 | 50 | 46 | 53 | 56 | 70 | 61 | 53 |
| Inventory days | 25 | 35 | 37 | 17 | 37 | 20 | 22 | 23 | 41 | 48 |
| Days payable | 39 | 49 | 49 | 57 | 59 | 44 | 49 | 58 | 49 | 48 |
| Cash conversion cycle | 26 | 26 | 24 | 9 | 23 | 29 | 29 | 35 | 54 | 53 |
| OCF / EBITDA % | 76.2% | 65.8% | 51.5% | — | 62.3% | 1.9% | n.m. | 66.4% | 38.6% | 99.6% |
| OCF / EBITDA % (3 years) | — | — | 64.3% | 70.0% | 68.0% | 49.8% | 44.7% | 36.0% | 57.7% | 69.7% |
| Debt / equity | 0.89 | 0.34 | 0.26 | 0.33 | 0.16 | 0.15 | 0.14 | 0.12 | 0.11 | 0.10 |
| Current ratio | 1.17 | 1.35 | 1.51 | 1.21 | 1.74 | 1.99 | 2.02 | 1.97 | 2.13 | 2.22 |
| Net debt / EBITDA | 1.60 | — | 0.71 | — | 0.31 | 0.76 | 1.48 | 1.21 | 0.86 | 0.52 |